Hajime Nakae
Shin Takayama
Takao Namiki- 1Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, Akita, Japan
- 2Department of Education and Support for Regional Medicine, Tohoku University Hospital, Sendai, Japan
- 3Department of Kampo Medicine, Tohoku University Hospital, Sendai, Japan
- 4Department of Japanese-Oriental (Kampo) Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
Editorial on the Research Topic
Potentials of Kampo Medicine in Modern Society
Public education of Traditional Japanese (Kampo) Medicine in Japan was abruptly stopped in 1895. As a result, Kampo went into steep decline. Nevertheless, Kampo medicine has gradually reemerged and now occupies a considerable position in the field of medical practice and education (1, 2). Its unforeseen significant effect is occasionally observed in patients with intractable diseases that western-style medicines don't work at all (3). Moreover, the Kampo concept of tonifying is used in persons with frailty or intractable infections such as MRSA or multi-drug-resistant Pseudomonas aeruginosa (4, 5).
It is also applicable in both emergency and intensive care units (6). For example, shakuyakukanzoto enables the rapid control of myalgia and is used to treat tetanus-induced convulsions (7). Goreisan is used for fluidTM1 disturbance and for the treatment of vertigo and acute gastroenteritis (8). Furthermore, blood TM1 disturbance is effective for the acute treatment of trauma. Hematoma is considered a form of static blood TM1; therefore, formulations that are useful for treating static blood TM1, such as keishibukuryogan and jidabokuippo, can be used (9–11). Satoh and Nakae reported that the administration of daijokito (DJT), which is composed of Magnolia bark, immature orange, rhubarb rhizome, and anhydrous mirabilitum, caused defecation in critically ill patients and significantly increased the stool volume. The anhydrous mirabilitum in DJT has a stool softening effect, and rhubarb rhizome has a hypermotility effect, and they are traditionally utilized couplings. Furthermore, Magnolia bark has psychotropic effects, and immature orange has anti-inflammatory effects. Such synergistic effects and multifunctionality are the strong points of Kampo medicine. While the negative effects of polypharmacy may occur to cover various effects with western medicines, the combination of crude drugs in Kampo medicine has been sophisticated throughout history.
In a medical environment that favors modern Western medicine, treatment with Kampo medicine is not common in emergency and critical care medicine. Nevertheless, treatments for acute infection, poisoning, or resuscitation are described in Shanghan Lun and Jin Gui Yao Lue, regarded as “emergency manuals,” both written by Zhang Zhongjing (150–219). We should apply such manuals as a gift of wisdom from ancestors and use them as suitable for our modern society. Kampo medicine might be applied to coronavirus disease 2019 (COVID-19) as well, since it has been used for viral infections such as influenza (12). Heat-clearing formula such as saikatsugekito is expected to prevent serious illness in mild cases (13–17). Tonic formula such as hochuekkito may prevent infections since it has multiple effects through the digestive and immune systems, including for acute viral infection and chronic inflammation (18, 19).
Thus, the quality of acute and chronic treatment strategies may be improved by taking advantage of all available medical resources and practices such as Western and Kampo medicines (Figure 1).
Figure 1. Hybrid-type treatment using Western and Kampo medicine.
Some adverse events that may present a risk of occurring in patients based on the known actions of the major active components of certain drugs are as follows; Ephedra herb, Glycyrrhiza root, Aconite tuber, rhubarb rhizome, and anhydrous mirabilitum (20). Yoshino et al. summarized clinical risk factors of Licorice-induced pseudoaldosteronism in this topic.
Now is the time to recognize Kampo medicine is effective in a variety of medical areas in a modern society.
Author Contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Conflict of Interest
ST belongs to the Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine, a joint research course with TSUMURA & Co. ST and TN received research funding from TSUMURA & Co.
The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Iizuka N, Usuku K, Nakae H, Segawa M, Wang Y, Ogashiwa K, et al. Web-based evaluation system to measure learning effectiveness in Kampo medicine. Evid Based Complement Alternat Med. (2016) 2016:2043535. doi: 10.1155/2016/2043535
2. Iizuka N, Nakae H, Segawa M, Tanaka K, Fujita Y, Ogihara H, et al. Web-based evaluation system for closing the education gap in Kampo medicine between facilities. Tradit Kampo Med. (2019) 6:12–8. doi: 10.1002/tkm2.1207
3. Irie Y, Nakae H, Hasunuma N, Hebiguchi M, Hiroshima Y, Okada Y, et al. Alopecia universalis successfully treated with kenchuto groups in a pediatric patient. Tradit Kampo Med. (2019) 6:178–81. doi: 10.1002/tkm2.1233
4. Nakae H, Hiroshima Y, Hebiguchi M. Kampo medicines for frailty in locomotor disease. Front Nutr. (2018) 5:31. doi: 10.3389/fnut.2018.00031
5. Nakae H, Yokoi A, Kato M, Akama T, Yamakawa T, Manabe M, et al. Five patients with severe burns and refractory infections treated using the traditional Japanese medicine Juzentaihoto. Pers Med Univers. (2013) 2:41–4. doi: 10.1016/j.pmu.2013.04.005
6. Nakae H, Irie Y. Relevance of Kampo in emergency and critical care medicine. Tradit Kampo Med. (2020) 7:63–8. doi: 10.1002/tkm2.1252
7. Nakae H, Irie Y, Satoh K, Kitamura T, Kameyama K, Nara T, et al. Treatment for tetanus applying Kampo medicine: administration of shakuyakukanzoto. Tradit Kampo Med. (2021) 8:130–7. doi: 10.1002/tkm2.1283
8. The The Editing Commitee for Dictionary of Kampo Medicine the Japan Society for Oriental Medicine editor. The Dictionary of Kampo Medicine (Basic Terms). Tokyo: The Editing Commitee for Dictionary of Kampo Medicine, the Japan Society for Oriental Medicine (2019).
9. Nakae H, Yokoi A, Kodama H, Horikawa A. Comparison of the effects on rib fracture between the traditional Japanese medicine jidabokuippo and nonsteroidal anti-inflammatory drugs: a randomized controlled trial. Evid Based Complement Alternat Med. (2012) 2012:837958. doi: 10.1155/2012/837958
10. Nakae H, Hebiguchi M, Okuyama M. Jidabokuippo use in patients with fractures of the extremities. Pers Med Univers. (2015) 4:66–9. doi: 10.1016/j.pmu.2014.10.002
11. Nakae H, Irie Y, Satoh K, Kameyama K, Kitamura T, Furuya T, et al. Traumatic asphyxia successfully treated with jidabokuippo. Tradit Kampo Med. (2020) 7:183–5. doi: 10.1002/tkm2.1260
12. Irie Y, Nakae H. The role of Kampo medicines in the pandemic of viral infections: learning from the Spanish flu. Kampo Med. (2020) 7:272–83. doi: 10.3937/kampomed.71.272
13. Irie Y, Nakae H, Fukui S. Three mild cases of coronavirus disease 2019 treated with saikatsugekito, a Japanese herbal medicine. Tradit Kampo Med. (2021) 8:111–4. doi: 10.1002/tkm2.1261
14. Irie Y, Nakae H, Fukui S. Treatment of coronavirus disease 2019 with saikatsugekito: a case series. Tradit Kampo Med. (2021) 8:211–20. doi: 10.1002/tkm2.1290
15. Arita R, Ono R, Saito N, Takayama S, Namiki T, Ito T, et al. Kakkonto, shosaikoto, platycodon grandiflorum root, and gypsum (a Japanese original combination drug known as saikatsugekito): pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to COVID-19. Tradit Kampo Med. (2020) 7:115–27. doi: 10.1002/tkm2.1258
16. Takayama S, Namiki T, Ito T, Arita R, Nakae H, Kobayashi S, et al. A multi-center, randomized controlled trial by the integrative management in japan for epidemic disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial. Trials. (2020) 21:827. doi: 10.1186/s13063-020-04746-9
17. Takayama S, Kashima M, Namiki T, Ito T, Ono R, Arita R, et al. Conventional and Kampo medicine in the treatment of mild to moderate COVID-19: A multicenter, retrospective observational study protocol by the integrative management in japan for epidemic disease (IMJEDI study-Observation). Tradit Kampo Med. (2021) 8:106–10. doi: 10.1002/tkm2.1271
18. Namiki T, Takayama S, Arita R, Ishii T, Kainuma M, Makino T, et al. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (integrative management in japan for epidemic disease by prophylactic study: IMJEDI P1 study). Trials. (2021) 22:23. doi: 10.1186/s13063-020-04939-2
19. Takayama S, Kikuchi A, Makino T, Kainuma M, Namiki T, Ito T. Basic pharmacological mechanisms and clinical evidence of the efficacy of Hochuekkito against infectious diseases and its potential for use against COVID-19. Tradit Kampo Med. (2021) 8:3–21. doi: 10.1002/tkm2.1264
Keywords: traditional Japanese medicine, Kampo, syakuyakukanzoto, keishibukuryogan, hochuekkito
Citation: Nakae H, Takayama S and Namiki T (2022) Editorial: Potentials of Kampo Medicine in Modern Society. Front. Nutr. 9:912874. doi: 10.3389/fnut.2022.912874
Received: 05 April 2022; Accepted: 11 May 2022;
Published: 14 June 2022.
Edited and reviewed by: Somasundaram Arumugam, National Institute of Pharmaceutical Education and Research, India
Copyright © 2022 Nakae, Takayama and Namiki. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hajime Nakae, bmFrYWVoJiN4MDAwNDA7ZG9jLm1lZC5ha2l0YS11LmFjLmpw